'Blue-sky' oyster vaccine has global potential say scientists

'Blue-sky' oyster vaccine has global potential say scientists
The Pacific oyster industry has struggled with a deadly virus since 2010. (Image: Moana NZ)
Greg Hurrell
The newest research into fighting a virus that devastated New Zealand’s multimillion-dollar Pacific oyster industry has global commercial potential despite its novel and “blue-sky nature”, scientists say.Nelson's independent Cawthron Institute has been granted $1 million over three years from the Endeavour Fund to develop a practical vaccine for Pacific oyster mortality syndrome (Poms), a goal previously thought impossible for shellfish.The Ministry of Business, Innovation and Employment (MBIE) administers the fund.The gra...

More Primary Sector

Synlait’s best move? Not getting rid of Dairyworks
Opinion Stock & Trade

Stock & Trade: Synlait’s best move? Not getting rid of Dairyworks

Consumer dairy goods business almost went in a Synlait fire sale.

Stock & Trade 28 Nov 2025
Pāmu upgrades profit guidance
Primary Sector

Pāmu upgrades profit guidance

That's despite this week's milk price cut.

Riley Kennedy 27 Nov 2025
Critical minerals miner plans 2026 NZX listing
Primary Sector

Critical minerals miner plans 2026 NZX listing

The company plans to raise $20m from retail investors in mid-2026.

Pattrick Smellie 26 Nov 2025
Ruminant Biotech closes $17 million series A raise
Primary Sector

Ruminant Biotech closes $17 million series A raise

The agritech start-up plans its commercial launch in NZ and Australia next year.

Greg Hurrell 26 Nov 2025